Medical Robotics and Computer-Assisted Surgery: The Global Market (focus on the Americas)

Report Code: HLC098A

Publish Date: Oct 2011

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for medical robotics and computer-assisted surgical (MRCAS) equipment was worth nearly $2 billion in 2010.  The market is projected to be $2.1 billion in 2011 and $3.6 billion by 2016 for a CAGR of 11.1% between 2011 and 2016. 
  • The overall North and South American market for MRCAS equipment and devices (other than the U.S.) was worth about $33 million in 2010.  BCC projects that the market will increase to $35 million in 2011 and $67 million by 2016, a CAGR of 13.9% over the next 5 years.
  • The U.S. market for medical robotics and computer-assisted surgical equipment was worth almost $1.4 billion in 2010.  The market is projected to approach $1.5 billion in 2011 and exceed $2.5 billion by 2016, a CAGR of 11.4%.

INTRODUCTION

STUDY BACKGROUND

Information technology plays a key role in an ever-widening range of human activities, including surgery.  Computers, working in tandem with a variety of microprocessor-enabled equipment and instruments, support and facilitate the work of the surgeon and have brought a level of safety and precision to surgery that would have been inconceivable just a few years ago.

These computers, electronic equipment, and instruments are referred to collectively as medical robotics and computer-assisted surgery (MRCAS) or, more dramatically, “the operating room of the future.”  MRCAS is used in a growing number of operating rooms around the world, largely as a result of the growing popularity of minimally invasive surgical (MIS) techniques.  Minimally invasive, or “keyhole” surgery is an alternative to traditional open-incision surgery in a growing number of procedures.  MIS utilizes special instruments that can be inserted and manipulated through small incisions (sometimes no more than a few millimeters long) under remote optical or video guidance, greatly reducing patient trauma and recovery times.

The need to perform delicate surgical procedures safely in tight spaces where the surgeon cannot see directly has created a growing market for devices that act as extensions of the surgeon’s eyes and hands: remote imaging, data processing and feedback, and robotics.  Meanwhile, MRCAS technology has been evolving, as have the medical and economic environments in which it is used.  Populations are aging, increasing demand for a wide range of age-related surgical procedures such as heart and orthopedic surgery.  Technological advances have expanded the range of surgical procedures that can be performed using minimally invasive techniques, making them accessible to even more people.

The structure of the hospital industry, the main user of MRCAS, is also changing as hospitals consolidate and other health care options such as walk-in surgical clinics become available to consumers.  Private and government health insurers around the world are becoming more cost-conscious, forcing hospitals to re-evaluate their capital spending plans but strengthening the case for technologies that can reduce the cost of surgical procedures.  Medical malpractice suits continue to be common in markets like the United States, so technologies that increase the precision and accuracy of surgery have obvious appeal. 

In such a fast-moving field, there is a pressing need to develop and maintain an up-to-date base of market information in order to better understand the dynamics of the market for MRCAS devices and equipment. 

GOALS AND OBJECTIVES

This report is an updated and expanded version of an earlier (2009) BCC Research analysis of U.S. and global markets for MRCAS equipment.  The updated report is based on the most recent market information available, and analyzes technological, economic, and regulatory developments that may have a long-term impact on the size and structure of the MRCAS market.  The new report also contains a more in-depth and detailed analysis of selected foreign markets than its predecessor.

More specific objectives of this report are to:

  • Identify and segment the main types of MRCAS devices that have been commercialized to date.
  • Analyze the historical and current volume and value of shipments of each of these product segments in specified applications and geographical markets.
  • Identify and evaluate the impact of demographic, economic, and other factors that will drive future demand for MRCAS devices.
  • Forecast the volume and value of product shipments by equipment type and application and by probabilities that future demand will be higher or lower than the baseline forecast.
  • Identify promising new surgical procedures and products still in the development and testing stage and assess the probability that they will be commercialized successfully within the next 5 years,
  • Forecast the potential market for these developmental procedures and products, taking into account the estimated probability that they will be commercialized.
  • Identify leading manufacturers of the devices and analyze the structure of the MRCAS industry (e.g., market shares, concentration, and recent M&A activity).
  • Assess the long-term outlook for MRCAS equipment, taking into account market opportunities as well as technological, financial, and economic factors.

INTENDED AUDIENCE

This report has been written for the entire MRCAS interest community, especially those in:

  • The medical and surgical devices industry
  • Medical research institutions
  • Investors
  • The financial and analyst community

Although the report is structured around specific technologies, it is largely non-technical in nature.  That is, it is concerned less with theory and jargon than with what works, how much of the latter the market is likely to purchase, and at what price.

As such, the report’s main audience is executive management and marketing and financial analysts. It is not written specifically for scientists and technologists, (although findings which concern the markets for their work, including the availability of government and corporate research funding for different technologies and applications) should interest them as well.

SCOPE AND FORMAT

This report is an analytical business tool with the primary purpose of describing the MRCAS equipment industry and the global market for these devices.  MRCAS equipment is defined as computer- or microprocessor-enabled devices and accessories that are physically situated in the operating room and directly assist the surgeon in planning and carrying out surgical procedures.  Thus, the scope of the study does not include:

  • Devices that provide images and other information but are not an integral part of the MRCAS system, such as preoperative imaging (e.g., CT, MRI) equipment, laboratory and other analytical devices.
  • Computerized medical records systems.
  • Electronic operating room equipment such as heart monitors that enable the surgical team to monitor the patient’s condition but do not assist the surgeon directly in carrying out the operation.
  • Other nonelectronic operating room equipment.

The format of the study is organized around the following topics:

  • Major types and applications of MRCAS
  • Industry structure
  • Market size and segmentation, including historical data on sales by application, product type, and geographical market
  • Market drivers
  • Detailed market projections through 2016
  • Competition and market shares
  • Observations and conclusions regarding the future of the MRCAS market

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this report. The findings and conclusions of this report are based on information gathered from manufacturers and users of MRCAS and other informed sources.  Interview data was combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2010.  With 2010 as a baseline, market projections were developed for 2011 to 2016.  The market projections are “consensus” projections, obtained by averaging market scenarios obtained from industry and other sources or developed independently by BCC.  The analytical methodologies BCC used to generate the market estimates are described in detail in the section on detailed market projections.

All dollar projections presented in this report are in 2010 constant dollars.

ANALYST CREDENTIALS

The author of this report is Andrew McWilliams.  Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel, LLC, is the author of several other BCC Research studies of the surgical and related medical devices markets, including the previous edition of this report; HLC051F − The Market for Minimally Invasive Medical Devices; HLC066B − Medical Automation Technologies, Products, and Markets; HLC038C − Patient Monitoring; HLC016D − Microelectronic Medical Implants: Products, Technologies, and Opportunities; HLC072A − Medical Lasers: Technologies and Global Markets; and HLC082A − Emerging Markets for Advanced Medical Technologies.

BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:

  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Medical Robotics and Computer-Assisted Surgery: The Global Market (focus on the Americas)169Free
Chapter- 1: INTRODUCTION5Free
Chapter- 2: EXECUTIVE SUMMARY 2Free
Chapter- 3: OVERVIEW 85Free
Chapter- 4: THE GLOBAL MARKET FOR MRCAS EQUIPMENT12Free
Chapter- 5: THE U.S. MARKET FOR MRCAS EQUIPMENT 32Free
Chapter- 6: OTHER NORTH AND SOUTH AMERICAN MARKETS FOR MRCAS EQUIPMENT 11Free
Chapter- 7: VENDOR PROFILES22Free

Related Reports

Medical Automation Technologies, Products and Markets

Published - Sep 2011 | Publisher - Andrew McWilliams | Code - HLC066B

The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.

The Market for Minimally Invasive Medical Devices

Published - Jun 2011 | Publisher - Andrew McWilliams | Code - HLC051F

The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010.  The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.

Microelectronic Medical Implants: Products, Technologies & Opportunities

Published - May 2011 | Publisher - Andrew McWilliams | Code - HLC016D

The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016. 

Telemedicine: Opportunities for Medical and Electronic Providers

Published - Jan 2011 | Publisher - Andrew McWilliams | Code - HLC014D

The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Medical Robotics and Computer-Assisted Surgery: The Global Market (focus on the Americas)
Customize Report